Luteinizing hormone-releasing hormone agonists and meningioma: A treatment dilemma

Urology

Volumn 62, Issue 2, 2003, Pages 351-

  Lee, Keith L ^b   Terris, Martha K ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN; STEROID;

ADULT; AGED; ARTICLE; AVASCULAR NECROSIS; BONE SCINTISCANNING; CANCER HORMONE THERAPY; CASE REPORT; CRANIOPLASTY; DRUG MEGADOSE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIOSURGERY; STEREOTAXIC SURGERY;

EID: 0043125505     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00256-5     Document Type: Article

References (9)

1. DeAngelis L.M. Brain tumors. N Engl J Med. 344:2001;114-123.
2. Gabos S., Berkel J. Meta-analysis of progestin and estrogen receptors in human meningiomas. Neuroepidemiology. 11:1992;255-260.
3. Maxwell M., Galanopoulos T., Neville-Golden J., et al. Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg. 78:1993;456-462.
4. Davis C. Meningiomas and sex hormones. Eur J Cancer. 26:1990;859-860.
5. Muccioli G., Ghe C., Faccani G., et al. Prolactin receptors in human meningiomas characterization and biological role . J Endocrinol. 153:1997;365-371.
6. Grunberg S.M. Role of antiprogestational therapy for meningiomas. Hum Reprod. 9:1994;202-207.
7. Olson J.J., Beck D.W., Schlechte J.A., et al. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg. 66:1987;584-587.
8. Durmaz R., Deliorman S., Isiksoy S., et al. Luteinizing hormone releasing hormone increases proliferation of meningioma cells in vitro. Arch Physiol Biochem. 107:1999;286-291.
9. van Groeninghen J.C., Kiesel L., Winkler D., et al. Effects of luteinising-hormone-releasing hormone on nervous-system tumours. Lancet. 352:1998;372-373.